M. Schechter, J. Scharf, and . Walsh, Zolpidem for Persistent Insomnia in SSRItreated Depressed Patients, The Journal of Clinical Psychiatry, vol.60, issue.10, pp.668-676, 1999.

L. Barbosa, M. Berk, and M. Vorster, A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes, The Journal of Clinical Psychiatry, vol.64, issue.4, pp.403-407, 2003.
DOI : 10.4088/JCP.v64n0407

M. Bauer and S. Dopfmer, Lithium Augmentation in Treatment-resistant Depression, 1999.

M. Bauer and S. Döpfmer, Lithium Augmentation in Treatment-resistant Depression, 2000.

M. Bauer, L. Dell-'osso, S. Kasper, W. Pitchot, E. D. Vansvik et al., Extended-release, 2013.

F. Benedetti, A. Pontiggia, A. Bernasconi, C. Colombo, M. Florita et al., Lormetazepam in Depressive Insomnia: New Evidence of Phase-response Effects of Benzodiazepines Acceleration and Augmentation of Antidepressants with Lithium for Depressive Disorders: Two Meta-analyses of Randomized, Placebo-controlled Trials, International Clinical Psychopharmacology The Journal of Clinical Psychiatry, vol.68, issue.6, pp.935-940, 2004.

M. Cullen, . Mitchell, . Brodaty, . Boyce, . Parker et al., Carbamazepine for Treatment-resistant Melancholia, The Journal of Clinical Psychiatry, vol.52, issue.11, pp.472-476, 1991.

J. Rush, H. Roy, and . Perlis, A Randomized, Double-blind, Placebo-controlled Trial of Pramipexole Augmentation in Treatment-resistant Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.74, issue.7, pp.636-641, 2013.

M. Brecher, Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: a Placebo-and Duloxetine-controlled Study, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.526-539, 2009.

J. De-la-gándara, J. Agüera, . Rojo, J. Ros, and . Pedro, Use of antidepressant combinations: which, when and why? Results of a Spanish survey, Acta Psychiatrica Scandinavica, vol.64, issue.1, pp.32-36, 2005.
DOI : 10.1016/S0197-2456(03)00112-0

C. Debattista, A. Solomon, B. Arnow, E. Kendrick, J. Tilston et al., The Efficacy of Divalproex Sodium in the Treatment of Agitation Associated With Major Depression, Journal of Clinical Psychopharmacology, vol.25, issue.5, pp.476-479, 2005.
DOI : 10.1097/01.jcp.0000177552.21338.b0

J. Dorée, J. Des-rosiers, V. Lew, A. Gendron, R. Elie et al., Quetiapine augmentation of treatment-resistant depression: a comparison with lithium, Current Medical Research and Opinion, vol.23, issue.2, pp.333-341, 2007.
DOI : 10.1185/030079906X162809

B. M. Kuehn, FDA Warns of Adverse Events Linked to Smoking Cessation Drug and Antiepileptics, JAMA, vol.299, issue.10, pp.1121-1122, 2008.
DOI : 10.1001/jama.299.10.1121

M. Ising and W. Kaschka, Outcome in Delusional Depression Comparing Trimipramine Monotherapy with a Combination of Amitriptyline and, 2009.

R. W. Lam, H. Sidney, S. Kennedy, . Grigoriadis, S. Roger et al., Arun V Ravindran, and Canadian Network for Mood and Anxiety Treatments (CANMAT), CANMAT) Clinical Guidelines for the Management, 2009.

C. Lin, S. Lin, and F. Jang, Adjunctive Low-dose, 2011.

B. Williams and I. Crombie, Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors Compared with Tricyclic Antidepressants in Depression Treated in Primary Care: Systematic Review and Meta-analysis, BMJ, p.326, 2003.

M. J. Canuso and G. Kujawa, Risperidone for Treatment-refractory Major Depressive Disorder: a Randomized Trial, Annals of Internal Medicine, vol.147, issue.9, pp.593-602, 2007.

. Randomized, Placebo-controlled Trials, BMC Psychiatry, vol.12, issue.160

D. Mischoulon, . Nierenberg, J. Kizilbash, M. Rosenbaum, and . Fava, Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-481, 2000.
DOI : 10.1177/070674370004500509

S. A. Montgomery, A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression, International Clinical Psychopharmacology, vol.16, issue.3, pp.169-178, 2001.
DOI : 10.1097/00004850-200105000-00006

M. Lader and R. W. Lam, Which Antidepressants Have Demonstrated Superior Efficacy? A Review of the Evidence, International Clinical Psychopharmacology, vol.22, issue.6, pp.323-329, 2007.

. Post-hoc, Pooled Analysis of Two Large, Placebo-controlled Studies, Journal of Affective Disorders, vol.12013, pp.133-140

J. Nelson, . Craig, I. George, and . Papakostas, Atypical Antipsychotic Augmentation in doi:10, 2009.

W. A. Nolen, P. Haffmans, H. Bouvy, and . Duivenvoorden, Hypnotics as concurrent medication in depression, Journal of Affective Disorders, vol.28, issue.3, pp.179-188, 1993.
DOI : 10.1016/0165-0327(93)90103-Q

R. B. Ostroff and J. Nelson, Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression, The Journal of Clinical Psychiatry, vol.60, issue.4, pp.256-259, 1999.
DOI : 10.4088/JCP.v60n0410

A. A. Patkar and C. Pae, Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder, CNS Drugs, vol.39, issue.8 Suppl. 2, pp.29-37, 2010.
DOI : 10.1007/s40263-012-0031-0

M. Rapaport, . Hyman, M. Georges, C. M. Gharabawi, . Canuso et al., Effects of Risperidone Augmentation in Patients with Treatment-resistant Depression: Results of Open-label Treatment Followed by Double-blind Continuation Amisulpride in Medium-term Treatment of Dysthymia: a Six-month, Double-blind Safety Study Versus Amitriptyline. AMILONG Investigators, Neuropsychopharmacology: Official Ravizza Journal of Psychopharmacology, issue.3, pp.13-248, 1999.

H. Reeves, S. Batra, S. Roberta, R. May, . Zhang et al., Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.69, issue.8, pp.1228-1336, 2008.
DOI : 10.4088/JCP.v69n0805

P. Rocca, V. Fonzo, L. Ravizza, G. Rocca, M. Scotta et al., A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder, Journal of Affective Disorders, vol.70, issue.3, pp.313-317, 2002.
DOI : 10.1016/S0165-0327(01)00327-5

A. J. Rothschild, J. Douglas, . Williamson, F. Mauricio, A. Tohen et al., A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features, Journal of Clinical Psychopharmacology, vol.24, issue.4, pp.365-373, 2004.
DOI : 10.1097/01.jcp.0000130557.08996.7a

A. Rush, . John, C. Helena, . Kraemer, A. Harold et al., Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder, Neuropsychopharmacology, vol.19, issue.9, pp.1841-1853, 2006.
DOI : 10.1038/sj.npp.1301131

A. Rush, . John, H. Madhukar, J. W. Trivedi, . Stewart et al., Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study, American Journal of Psychiatry, vol.168, issue.7, pp.689-701
DOI : 10.1176/appi.ajp.2011.10111645

M. E. Nierenberg, L. Thase, and . Ritz, Bupropion-SR, Sertraline, or venlafaxine-XR after Failure of SSRIs for Depression, The New England Journal of Medicine, vol.354, issue.12, pp.1231-1242, 2006.

F. Schindler, G. Ion, and . Anghelescu, Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study, International Clinical Psychopharmacology, vol.22, issue.3, pp.179-182, 2007.
DOI : 10.1097/YIC.0b013e328014823d

B. Schmitz, Antidepressant Drugs: Indications and Guidelines for Use in Epilepsy, Epilepsia, vol.27, issue.2, pp.14-18, 2002.
DOI : 10.1046/j.1528-1157.2002.043s2014.x

M. Bahk, Effect of Augmented Atypical Antipsychotics on Weight Change in Patients with Major Depressive Disorder in a Naturalistic Setting, Human Psychopharmacology, vol.24, issue.2, pp.135-143, 2009.

E. Smeraldi, Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study, Journal of Affective Disorders, vol.48, issue.1, pp.47-56, 1998.
DOI : 10.1016/S0165-0327(97)00139-0

L. Tarsitani and M. Pasquini, Compared with fluoxetine monotherapy, mirtazapine plus venlafaxine or fluoxetine increase remission but not response in patients with major depressive disorder, Evidence-Based Mental Health, vol.13, issue.3, 2010.
DOI : 10.1136/ebmh1061

M. E. Thase, A. Sara, O. Corya, M. Osuntokun, . Case et al., A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.68, issue.02, pp.224-236, 2007.
DOI : 10.4088/JCP.v68n0207

M. E. Thase, S. Edward, M. M. Friedman, . Biggs, R. Stephen et al., Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report, American Journal of Psychiatry, vol.164, issue.5, pp.739-752, 2007.
DOI : 10.1176/ajp.2007.164.5.739

D. Quitkin, L. Warden, and . Ritz, Medication Augmentation after the Failure of SSRIs for Depression, The New England Journal of Medicine, vol.354, issue.12, pp.1243-1252, 2006.

J. Thomas, T. Carmody, and . Key, Clinical Results for Patients with Major Depressive Disorder in the Texas Medication Algorithm Project, Archives of General Psychiatry, vol.61, issue.7, pp.669-680, 2004.

. Trivedi, H. Madhukar, J. Rush, R. Stephen, . Wisniewski et al., Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice, American Journal of Psychiatry, vol.163, issue.1, pp.28-40, 2006.
DOI : 10.1176/appi.ajp.163.1.28

M. Valenstein, K. Taylor, K. Austin, C. Helen, . Kales et al., Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings, American Journal of Psychiatry, vol.161, issue.4, pp.654-661, 2004.
DOI : 10.1176/appi.ajp.161.4.654

. Wisniewski, The STAR*D Project Results: a Comprehensive Review of Findings, Current Psychiatry Reports, vol.9, issue.6, pp.449-459, 2007.

B. Berman and . Carlson, Analysis of Suicidality in Pooled Data from 2 Doubleblind , Placebo-controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.72, issue.4, pp.548-555, 2011.

B. M. Wright, H. Edward, R. Eiland, and . Lorenz, Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.352, issue.11, pp.344-359, 2013.
DOI : 10.1002/phar.1204

A. Yoshino, T. Sawamura, N. Kobayashi, S. Kurauchi, A. Matsumoto et al., Algorithm-guided treatment versus treatment as usual for major depression, Psychiatry and Clinical Neurosciences, vol.12, issue.5, pp.652-657, 2009.
DOI : 10.1111/j.1440-1819.2009.02009.x